Analytical validation of anti-toxoplasma IgG immunoassays

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 6, 2012, Pages 574-576

  Souza, Guenael Freire de ^a   Carvalho, Darlene ^a   Pedrosa, William ^a   Franck, Jacqueline ^b   Piarroux, Renaud ^b  

^a Instituto Hermes Pardini   (Brazil)

^b TIMONE HOSPITAL   (France)

Author keywords

ECLIA; ELFA; Immunoassay; Toxoplasma

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANALYTIC METHOD; ARTICLE; CHEMOLUMINESCENT IMMUNOASSAY; ELECTROCHEMOLUMINESCENT IMMUNOASSAY; ENZYME LINKED FLUORESCENT ASSAY; HUMAN; IMMUNOASSAY; NONHUMAN; SENSITIVITY AND SPECIFICITY; TOXOPLASMA GONDII; TOXOPLASMOSIS; VALIDATION PROCESS; WESTERN BLOTTING;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, PROTOZOAN; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; LUMINESCENT MEASUREMENTS; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84870398496     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.07.014     Document Type: Article

References (8)

1. Lopes F.M.R., Mitsuka-Breganó R., Gonçalves D.D., et al. Factors associated with seropositivity for anti-Toxoplasma gondii antibodies in pregnant women of Londrina, Paraná, Brazil. Mem Inst Oswaldo Cruz 2009, 104:378-382.
2. Gonçalves M.A., Matos C., de C., Spegiorin L.C., Oliani D.C., Oliani A.H., Mattos L.C. Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo State, Brazil. Braz J Infect Dis 2010, 14:601-605.
3. Villena I., Ancelle T., Delmas C., et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 2010, 15. pii: 19600.
4. Montoya J., Remington J. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008, 47:554-566.
5. Franck J., Garin Y., Dumon H., LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol 2008, 46:2334-2338.
6. Clinical use and interpretation of serologic tests for Toxoplasma gondii. Approved guideline M36-A 2004, National Committee for Clinical Laboratory Standard, NCCLS, Wayne, PA.
7. Leslé F., Touafek F., Fekkar A., Mazier D., Paris L. Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot. Eur J Clin Microbiol Infect Dis 2011, 30:1207-1212.
8. Maudry A., Chene G., Chatelain R., et al. Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clin Vaccine Immunol 2009, 16:1322-1326.